Trial intelligence / Profile preview

Naproxen Sodium and Acetaminophen for Postoperative Dental Pain

NCT03879408Phase 2Completed

Sponsor
Johnson & Johnson
Start
May 2019
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Aprol, acetaminophen in odontalgia, sponsored by Johnson & Johnson. Started May 2019; status: completed.

02

Drugs

Aprolacetaminophen
03

Conditions

odontalgia

Beyond the preview

Go deeper on NCT03879408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03879408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call